[1] |
鲁正, 王冬冬. Bismuth-Corlette Ⅲ, Ⅳ型肝门部胆管癌的手术治疗方式[J]. 中华外科杂志, 2016(7): 488-491.
|
[2] |
Hu HJ, Mao H, Shrestha A, et al. Prognostic factors and longterm outcomes of hilar cholangiocarcinoma: a single-institution experience in China[J]. World J Gastroenterol, 2016, 22(8): 2601-2610.
|
[3] |
高龙, 吴越, 闫海丽, 等. 肝内胆管癌的局部治疗现状与研究进展[J]. 中华放射学杂志, 2021, 55(10): 1103-1107.
|
[4] |
许冰华, 蒋莉莉. 影响肝门部胆管癌致梗阻性黄疸介入引流治疗预后的相关危险因素[J]. 影像研究与医学应用, 2017, 1(15): 219-221.
|
[5] |
郭俊, 赵文军, 吕洋, 等. 肝门部胆管癌高位多支复杂胆道梗阻的介入引流方法探讨[J]. 中华介入放射学电子杂志, 2018, 6(4): 301-305.
|
[6] |
杨安, 刘玉娥, 申景. 肝门部胆管癌的介入治疗现状及研究进展[J]. 介入放射学杂志, 2021, 30(3): 312-316.
|
[7] |
Xu C, Lv PH, Huang XE, et al. Internal-external percutaneous transhepatic biliary drainage for patients with malignant obstructive jaundice[J]. Asian Pac J Cancer Prev, 2014, 15(21): 9391-9394.
|
[8] |
郭晋芳, 张健康. 胆道支架植入及IRE治疗肝门部胆管癌的研究进展[J]. 现代消化及介入诊疗, 2021, 26(9): 1190-1193.
|
[9] |
但汉雷, 丁雷, 田伏洲, 等. 经皮经肝胆管腔内射频消融疏通肝门部胆管癌性梗阻[J]. 现代消化及介入诊疗, 2021, 26(1): 6-9.
|
[10] |
Kim KM, Jeong CU, Shim SG, et al. Efficacy and safety of compound tri-metal stent Placement for malignant Perihilar biliary obstruction[J]. Niger J Clin Pract, 2018, 21(9): 1121-1126.
|
[11] |
李刚, 王全义, 苏金旺, 等. 新型(125)I双链胆道引流管治疗胆管癌合并黄疸的近期疗效(附9例报告)[J]. 中华介入放射学电子杂志, 2021, 9(4): 403-406.
|
[12] |
陈建建, 姚远, 周学良, 等. 金属支架联合腔道内抗肿瘤技术治疗恶性胆道梗阻的研究现状及进展[J]. 中华介入放射学电子杂志, 2019, 7(2): 163-167.
|
[13] |
Tang K, Sui LL, Xu G, et al. Effects of different palliative jaundice reducing methods on immunologic functions in patients with advanced malignant obstructive jaundice[J]. Anticancer Res, 2017, 37(8): 4665-4670.
|
[14] |
Zhang GY, Li WT, Peng WJ, et al. Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice[J]. Oncol Lett, 2014, 7(4): 1185-1190.
|
[15] |
Afshar M, Khanom K, Ma YT, et al. Biliary stenting in advanced malignancy: an analysis of predictive factors for survival[J]. Cancer Manag Res, 2014, 6: 475-479.
|
[16] |
陈伟伟, 黄坤, 刘锐, 等. 经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析[J]. 临床肝胆病杂志, 2019, 35(3): 559-564.
|
[17] |
Hyun H, Choi SY, Kim KA, et al. Safety and efficacy of percutaneous biliary covered stent placement in patients with malignant biliary hilar obstruction; correlation with liver function[J]. Cardiovasc Intervent Radiol, 2016, 39(9): 1298-1305.
|
[18] |
王继蕊, 林梅青, 赵久晗, 等. 合并恶性肿瘤的脑梗死的临床特点及影响预后的相关因素分析[J]. 中国卒中杂志, 2021, 16(2): 136-140.
|
[19] |
高劲, 胡婧晔, 夏云飞. 血红蛋白持续下降是鼻咽癌放疗患者的不良预后因素[J]. 癌症, 2010, 29(5): 561-566.
|
[20] |
侯东泽, 代劲松, 邓志波, 等. 血红蛋白水平与围手术期输血对结肠癌患者预后的影响[J]. 现代肿瘤医学, 2018, 26(7): 1070-1074.
|